Carriage of ESBL- And AmpC-positive Enterobacteriaceae in the gastrointestinal tract of community subjects and hospitalized patients in the Czech Republic

Biomedical Papers

Volumn 156, Issue 4, 2012, Pages 348-353

  Husickova, Vendula ^a   Cekanova, Luboslava ^a   Chroma, Magdalena ^a   Htoutou Sedlakova, Miroslava ^a   Hricova, Kristyna ^a   Kolar, Milan ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

AmpC; Carriage; ESBL; GIT

Indexed keywords

AMPC BETA LACTAMASES; AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE;

ARTICLE; BIOSYNTHESIS; CZECH REPUBLIC; ENTEROBACTERIACEAE; ENZYMOLOGY; GASTROINTESTINAL TRACT; HETEROZYGOTE; HOSPITAL PATIENT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; CZECH REPUBLIC; ENTEROBACTERIACEAE; GASTROINTESTINAL TRACT; HUMANS; INPATIENTS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE;

EID: 84872016934     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2012.039     Document Type: Article

References (28)

1. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:3720-8.
2. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-86.
3. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-ß-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007;51:1987-94.
4. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-62.
5. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7.
6. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13(47): pii=19044. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044
7. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum β-lactamase producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(Suppl. 1):144-53.
8. Valverde A, Coque TM, Sanchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004;42:4769-75.
9. Qin X, Zerr DM, Weissman SJ, Englund JA, Denno DM, Klein EJ, Tarr PI, Kwong J, Stapp JR, Tulloch LG, Galanakis E. Prevalence and mechanisms of broad-spectrum β-lactam resistance in Enterobacteriaceae: a children's hospital experience. Antimicrob Agents Chemother 2008;52:3909-14.
10. Pitout JD, Gregson DB, Church DL, Laupland KB. Populationbased laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007;13:443-8.
11. Hammerum AM, Lester CH, Jakobsen L, Porsbo LJ. Faecal carriage of extended-spectrum β-lactamase-producing and AmpC β-lactamase-producing bacteria among Danish army recruits. Clin Microbiol Infect 2011;17:566-8.
12. Cekanova L, Kolar M, Chroma M, Sauer P, Sedlácková M, Koukalová D. Prevalence of ESBL-positive bacteria in the community in the Czech Republic. Med Sci Monit 2009;15(7): BR202-6.
13. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broadspectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.
14. Kolář M. Clinical significance of broad-spectrum ß-lactamases and experience with their identification in microbiological practice. Klin Mikrobiol Inf Lék 2007;13(5): 195-205.
15. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, Shibata N, Kato H, Shibayama K, Arakawa Y. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005;43:2551-8.
16. Arlet G, Brami G, Décrè D, Flippo A, Gaillot O, Lagrange PH, Philippon A. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol Lett 1995;134:203-8.
17. Chanawong A, M'Zali F, Heritage J, Lulitanond, A, Hawkey PM. Characterisation of extended-spectrum β-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (PCR-RFLP). FEMS Microbiol Lett 2000;184:85-9.
18. Pagani L, Dell'Amico E, Migliavacca R, D'Andrea MM, Giacobone E, Amicosante G, Romero E, Rossolini GM. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 2003;41:4264-9.
19. Minarini LA, Gales AC, Palazzo IC, Darini AL. Prevalence of community-occuring extended spectrum β-lactamase-producing Enterobacteriaceae in Brazil. Curr Microbiol 2007;54(5):335-41.
20. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40:2153-62.
21. Livermore DM, Paterson DL. Pocket guide to extended spectrum ß-lactamases in resistance. Current Medicine Group Ltd, Spain, 2006.
22. Castillo García FJ, Seral García C, Pardos De la Gandara M, Millán Lou MI, Pitart Ferré C. Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods. Eur J Clin Microbiol Infect Dis 2007;26:77-8.
23. Munday CJ, Whitehead GM, Todd NJ, Campbell M, Hawkey PM. Predominance and genetic diversity of community and hospital acquired CTX-M extended-spectrum ß-lactamases in York, UK. J Antimicrob Chemother 2004;54:628-33.
24. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamaseproducing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62:1142-9.
25. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004;54:735-43.
26. Vinue L, Saenz Y, Martinez S, Somalo S, Moreno MA, Torres C, Zarazaga M. Prevalence and diversity of extended-spectrum betalactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009;15:954-7.
27. Janvier F, Mérens A, Delaune D, Soler C, Cavallo JD. Portage digestif d'entérobactéries résistantes aux céphalosporines de troisième génération dans une population d'adultes jeunes asymptomatiques: évolution entre 1999 et 2009. Pathol Biol (Paris) 2010. doi: 10.1016/j.patbio.2010.07.012
28. Kaneko K, Sato Y, Tokunaga S, Tamaki SK, Okamoto R, Inoue M. AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers. J Antimicrob Chemother 2006;57:369-71.